Paternal Exposure to Cyclophosphamide Dysregulates the Gene Activation Program in Rat Preimplantation Embryos

• Published in: Molecular reproduction and development 2000-11, Vol.57 (3), p.214-223
• Main Authors: Harrouk, W, Khatabaksh, S, Robaire, B, Hales, B F
• Format: Article
• Language: English
• Subjects: Cyclophosphamide
• ISSN: 1040-452X
• DOI: 10.1002/1098-2795(200011)57:3<214::AID-MRD2>3.3.CO;2-4

Although there has been progress in determining the mechanisms by which maternal toxicant exposure affects progeny, there is little information on the actions of drugs administered to the father. We investigated the effects of pre-conceptional paternal exposure to cyclophosphamide, an anticancer agent, on embryonic gene activation in the rat. The male pronucleus was formed earlier in embryos sired by cyclophosphamide-treated male rats than in those sired by controls; early male pronucleus formation was followed by alterations in the gene activation program. BrUTP incorporation into RNA and Sp1 transcription factor immunostaining were increased and spread over both cytoplasmic and nuclear compartments in 2-cell embryos sired by cyclophosphamide-treated males compared to controls. Total RNA synthesis was constant in 1-8 cell embryos sired by drug-treated fathers, while in control embryos RNA synthesis increased four-fold to peak at the 4-cell stage. In 2-cell embryos sired by drug-treated males, the relative abundance of candidate imprinted genes was elevated significantly above control; a peak in the expression of these genes was not observed until the 8-cell stage in control embryos. Thus, paternal drug exposure temporally and spatially dysregulated rat zygotic gene activation, altering the developmental clock.